The January 2013 Issue of The Burrill Report - 12/21/2012

UCSF Chancellor Leaving to Head Gates Foundation
Desmond-Hellmann will bring extensive drug-development and administrative experience to foundation. Read More
Fixing the Life Sciences with the
Lean Startup
Podcast: December 23, 2013 Read More
Biotech Visionary G. Steven Burrill Offers Predictions for 2014
Sees sector maintaining momentum in the new year, but at a slower pace as valuations return to normal Read More
Biogen and Samsung to Market Biosimilars in Europe
Agreement advances joint venture’s pursuit of potentially lucrative market. Read More
Covidien Buys Given Imaging for $860M
Israeli GI diagnostics maker’s novel PillCam lets doctors see the digestive tract less invasively. Read More
Roche Taps Prothena for Parkinson’s Drug
Collaboration for early-stage therapy worth up to $600 million for Irish biotech. Read More
Avanir Falls as MS Drug Misses Primary Endpoint in Mid-Stage Trial
The weekly round-up of failed trials, missed targets, and other business mishaps. Read More
Why Standards Are Needed to Fix Life Sciences Research
Podcast: December 16, 2013 Read More
Scientists Create Drug Response Biosensor
Modular system could move continuous monitoring beyond diabetics to wider range of applications. Read More
Making the U.S. More Competitive
Small business forum discusses public policies to encourage investment in innovative R&D; companies. Read More

[Please login to post comments]